GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Rising Biosciences Inc (GREY:RBII) » Definitions » Sale Of Investment

Rising Biosciences (Rising Biosciences) Sale Of Investment : $ Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is Rising Biosciences Sale Of Investment?

Rising Biosciences's sale of investment for the three months ended in . 20 was $0.00 Mil. It means Rising Biosciences gained $0.00 Mil from selling investments.

Compared with last quarter ($0.00 Mil in . 20 ), Rising Biosciences gained the same money from selling investments in . 20 ($0.00 Mil).


Rising Biosciences Sale Of Investment Historical Data

The historical data trend for Rising Biosciences's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rising Biosciences Sale Of Investment Chart

Rising Biosciences Annual Data
Trend
Sale Of Investment

Rising Biosciences Quarterly Data
Sale Of Investment

Rising Biosciences Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.


Rising Biosciences Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Rising Biosciences's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Rising Biosciences (Rising Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
1180 Cleveland Road, Sandusky, OH, USA, 44870
Rising Biosciences Inc is a United States-based company engaged in research and development activities. It is focused on oral and topical cannabis and non-cannabis based pharmaceuticals. The company seeks to address the market demand for the treatment of the danger of opiates, whose long-term effects can include liver damage, addiction and brain damage due to hypoxia, resulting from respiratory depression, among other complications.

Rising Biosciences (Rising Biosciences) Headlines

From GuruFocus

PAOG Officially Appoints Karl Riedel as New CEO and President

By Marketwired Marketwired 02-11-2019